ICU Medical, Inc. - Common Stock (NQ:ICUI)

163.91 +3.59 (+2.24%)

Delayed Quote Updated: 4:00 PM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ICU Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

TC BioPharm Ltd ($TCBP) leads fight against Acute myeloid leukemia with its cell therapy product OmnImmune

November 22, 2022

Via AB Newswire

Topics Death Economy Stocks

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 ↗

November 08, 2022

Upgrades

Via Benzinga

ICU Medical Announces Third Quarter 2022 Results

November 07, 2022

The Company Reaffirms 2022 Fiscal Year Guidance

From ICU Medical, Inc.

Via GlobeNewswire

FDA Signals Shortage Of ICU Medical's Tracheostomy Tubes ↗

November 01, 2022

Via Benzinga

Smiths Acquisition Weighs On ICU Medical's Profitability, Shares Fall ↗

August 09, 2022

Via Benzinga

Tesla Shifts China Factory Workers To US Plant, Complete European Approval For AstraZeneca's COVID-19 Shot, Tesla Eyes Cybertruck Commercialization From Next Year: Top Stories Tuesday, Nov. 01 ↗

November 01, 2022

Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production

Via Benzinga

ICU Medical Announces Time of Third Quarter 2022 Earnings Conference Call

October 06, 2022

From ICU Medical, Inc.

Via GlobeNewswire

Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock ↗

August 09, 2022

Mizuho boosted the price target for Karuna Therapeutics, Inc. (NASDAQ: KRTX) from $190 to $276. Karuna Therapeutics shares fell 1.3% to $238.00 in pre-market trading.

Via Benzinga

This Analyst Lowers Price Target On Lyft; Also Check Out Some Other Major PT Changes ↗

August 08, 2022

Wells Fargo cut the price target on Lyft, Inc. (NASDAQ: LYFT) from $49 to $42. However, Wells Fargo analyst Brian Fitzgerald maintained the stock with an Overweight. Lyft shares rose 0.6% to $20.41 in...

Via Benzinga

Raymond James Says 'Supply Chain Challenges Made Q1 Messy' For This Medtech Stock ↗

May 11, 2022

Via Benzinga

Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday ↗

August 10, 2022

U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

ICU Medical's Return On Capital Employed Insights ↗

June 02, 2022

ICU Medical (NASDAQ:ICUI) brought in sales totaling $543.12 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 291.06%, resulting in a loss of $38.07 million.

Via Benzinga

Morgan Stanley And 2 Other Stocks Insiders Are Buying ↗

May 16, 2022

Although US stocks closed sharply higher on Friday, there were a few notable insider trades.

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

Expert Ratings for ICU Medical ↗

August 09, 2022

Analysts have provided the following ratings for ICU Medical (NASDAQ:ICUI) within the last quarter:

Via Benzinga

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗

August 09, 2022

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....

Via Benzinga

ICU Medical: Q2 Earnings Insights ↗

August 08, 2022

ICU Medical (NASDAQ:ICUI) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

May 10, 2022

Keybanc cut PubMatic, Inc. (NASDAQ: PUBM) price target from $48 to $27. PubMatic shares fell 1.5% to $18.71 in pre-market trading.

Via Benzinga

The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More ↗

May 09, 2022

Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:...

Via Benzinga

UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market ↗

March 05, 2022

Health care stocks have some advantages in the current market environment.

Via Investor's Business Daily

Recap: ICU Medical Q4 Earnings ↗

February 24, 2022

ICU Medical (NASDAQ:ICUI) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings ICU...

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs ↗

January 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hepion's Lead NASH Drug Candidate Gets The Non-Proprietary Name...

Via Benzinga

ICU Medical, inc (ICUI) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

ICUI earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗

November 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...

Via Benzinga

Topics Retirement

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

ICU Medical Pulls Amino Acid IV Products After Foreign Substances Found In Batch ↗

September 09, 2021

ICU Medical Inc (NASDAQ: ICUI), a California-based infusion therapy company, is voluntarily recalling one lot of an amino acid injection after reports of fibers,...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

September 09, 2021

Telsey Advisory Group lifted the price target on Lululemon Athletica Inc. (NASDAQ: LULU) from $460 to $485. Lululemon shares surged 13.9% to $433.58 in pre-market trading....

Via Benzinga

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.